Cutaneous adverse drug reaction induced by a generic substitute of Zyloric® with a residual sensitization to allopurinol

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 61, Issue 12, 2006, Pages 1492-1493

  Chandeclerc, M L ^a   Trechot P ^b   Martin, S ^b   Weber Muller, F ^b   Schmutz, J L ^b   Barbaud, A ^b  

^a SERVICE DE DERMATOLOGIE   (France)

^b NONE

Author keywords

Allopurinol; Cutaneous adverse drug reaction; Generic substitute; Zyloric

Indexed keywords

ALLOPURINOL; EXCIPIENT; GENERIC DRUG;

ARTICLE; DRUG SUBSTITUTION; DRUG TOLERABILITY; HISTOPATHOLOGIC SKIN REACTION; HUMAN; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DISEASE; SKIN SENSITIZATION;

ALLOPURINOL; DRUG HYPERSENSITIVITY; DRUGS, GENERIC; HUMANS; MALE; MIDDLE AGED; PARAPSORIASIS;

EID: 33750527568     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01199.x     Document Type: Article

References (3)

1. Busch RL. Generic carbamazepine and erythema multiforme: generic drug non-equivalency. N Engl J Med 1989;321:692-693.
2. Barbaud A. Place of excipients in drug related allergy. Clin Rev Allergy Immunol 1995;13:253-263.
3. Barbaud A, Goncalo M, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reaction. Contact Dermat 2001;45:321-328.